KRAS and cancer: This idea is supported by the observation that K-RAS mutation is a relatively late event in the pathogenesis of human lung adenocarcinoma: K-RAS mutations appear to be involved in the conversion of dysplastic cells to preinvasive cancer cells, rather than initiation of preneoplastic lesions.46